Reuters logo
BRIEF-Novozymes Q3 EBIT above expectations at DKK 1.06 bln
October 25, 2017 / 6:24 AM / in a month

BRIEF-Novozymes Q3 EBIT above expectations at DKK 1.06 bln

Oct 25 (Reuters) - NOVOZYMES:

* ‍FULL-YEAR OUTLOOK ADJUSTED​

* ‍NOW EXPECTS ORGANIC REVENUE GROWTH 3-5% (2-5%)​

* NOVOZYMES - STILL SOME UNCERTAINTY REGARDING AGRICULTURE-RELATED MARKETS IN Q4‍​

* NOW EXPECTS ‍DKK REVENUE GROWTH 2-4% (1-4%)​

* NOW EXPECTS ‍EBIT GROWTH 2-4% (1-4%)​

* Q3 SALES DKK ‍​3.58 BILLION (REUTERS POLL DKK 3.54 BILLION)

* Q3 EBIT DKK ‍​1.06 BILLION (REUTERS POLL DKK 1.01 BILLION)

* Q3 NET PROFIT 819 MILLION (REUTERS POLL DKK 789 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below